The NIH Clinical Center is a hospital solely dedicated to clinical research at the National Institutes of Health campus in Bethesda, Maryland.

During the past decade, National Institutes of Health Clinical Center conducted 864 clinical trials. In the 10-year time frame, 864 clinical trials started and 135 clinical trials were completed, i.e. on average, 15.6% percent of trials that started reached the finish line to date. In the past 5 years, 454 clinical trials started and 122 clinical trials were completed. i.e. 26.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Institutes of Health Clinical Center" #1 sponsor was "National Cancer Institute (NCI)" with 497 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 180 trials sponsored, "National Institutes of Health Clinical Center (CC)" with 170 trials sponsored, "National Heart, Lung, and Blood Institute (NHLBI)" with 114 trials sponsored and "National Institute of Neurological Disorders and Stroke (NINDS)" with 114 trials sponsored. Other sponsors include 439 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institutes of Health Clinical Center" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "National Institutes of Health Clinical Center (CC)" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 8 trials as a collaborator and "National Institutes of Health (NIH)" with 7 trials as a collaborator. Other collaborators include 166 different institutions and companies that were collaborators in the rest 111 trials.

According to Clinical.Site data, the most researched conditions in "National Institutes of Health Clinical Center" are "Healthy Volunteers" (51 trials), "Breast Cancer" (38 trials), "Prostate Cancer" (37 trials), "Lymphoma" (36 trials) and "Healthy" (32 trials). Many other conditions were trialed in "National Institutes of Health Clinical Center" in a lesser frequency.

Most popular intervention types in "National Institutes of Health Clinical Center" are "Drug" (576 trials), "Biological" (224 trials), "Other" (125 trials), "Procedure" (108 trials) and "Device" (82 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Cyclophosphamide" (34 trials), "Fludarabine" (26 trials), "Computed Tomography" (21 trials) and "Laboratory Biomarker Analysis" (21 trials). Other intervention names were less common.

The vast majority of trials in "National Institutes of Health Clinical Center" are 1398 trials for "All" genders, 64 trials for "Female" genders and 45 trials for "Male" genders.

Currently, there are 897 active trials in "National Institutes of Health Clinical Center". 25 are not yet recruiting, 710 are recruiting, 114 are Active, not recruiting, and 48 are Enrolling by invitation. In total, there were 502 completed trials in National Institutes of Health Clinical Center, 12 suspended trials, and 70 terminated clinical trials to date.

Out of the total trials that were conducted in National Institutes of Health Clinical Center, 349 "Phase 1" clinical trials were conducted, 431 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 91 trials that are defined as “Not Applicable".